Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Pharmaceuticals SPDR
(NY:
XPH
)
39.30
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
39.30
Bid (Size)
38.74 (39)
Ask (Size)
40.24 (37)
Prev. Close
39.30
Today's Range
39.30 - 39.30
52wk Range
34.67 - 45.62
Shares Outstanding
48,502
Dividend Yield
1.22%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Performance
YTD
-5.71%
-5.71%
1 Month
-7.11%
-7.11%
3 Month
-6.74%
-6.74%
6 Month
+8.59%
+8.59%
1 Year
-7.20%
-7.20%
More News
Read More
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Via
Talk Markets
Topics
ETFs
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Via
Benzinga
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Via
Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Via
Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
Via
Talk Markets
3 Pharma Stocks Yielding Over 3%
January 18, 2022
Via
Talk Markets
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Via
InvestorPlace
The Bear Market Is Already Here – But Not For Dividend Investors
December 22, 2021
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
Via
Talk Markets
The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour
August 20, 2021
Via
Talk Markets
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
The 2 Best Pharma Stocks to Buy on Dips
June 23, 2021
Via
Talk Markets
Exposures
COVID-19
3 Top Pharma Stocks to Buy This Month
June 09, 2021
Via
Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.